Igor Cima

Title: Igor Cima: Innovator in Cancer Biomarker Discovery

Introduction

Igor Cima is a notable inventor based in Torre-Blenio, Switzerland. He has made significant contributions to the field of cancer diagnostics, particularly in the discovery of biomarkers for prostate cancer. With a total of 2 patents, his work is paving the way for advancements in cancer treatment and diagnosis.

Latest Patents

Cima's latest patents focus on methods for biomarker and drug-target discovery for prostate cancer diagnosis and treatment. One of his inventions relates to biomarker assays based on protein and peptide biomarkers that exhibit pronounced differential behavior between healthy and cancerous sample proteomes. This includes techniques such as mass spectrometric measurement and antibody-based assays like Enzyme-Linked Immunosorbent Assay (ELISA) for determining protein biomarkers in serum, plasma, or blood. Another patent outlines a comprehensive method for identifying potential candidate protein and peptide biomarkers and drug-targets, which involves several steps including the measurement of protein concentrations in tissue samples and the application of statistical methods to uncover biomarkers for cancer detection.

Career Highlights

Igor Cima has worked with prestigious institutions such as ETH Zurich and Kantonsspital St. Gallen. His experience in these organizations has contributed to his expertise in the field of biomarker research and cancer diagnostics.

Collaborations

Cima has collaborated with notable professionals in his field, including Wilhelm Krek and Rudolf Aebersold. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Igor Cima's work in cancer biomarker discovery is crucial for the advancement of diagnostic methods for prostate cancer. His innovative patents and collaborations reflect his commitment to improving cancer treatment and patient outcomes.